Authors


G. Jonathan Lewis, DO, MPH

Latest:

Screening Cardiac Surgery Patients for MRSA: An Economic Computer Model

Routine preoperative MRSA screening of cardiac surgery patients could provide substantial economic value to third-party payers and hospitals under a wide range of circumstances.



Arnold Saperstein, MD

Latest:

Randomized Trial of an Electronic Asthma Monitoring System Among New York City Children

Children who used an electronic monitoring system had as many emergency department visits and hospitalizations for asthma as children who used a paper diary.


Ann S. M. Harada, PhD

Latest:

Clinical and Economic Outcomes Associated With Potentially Inappropriate Prescribing in the Elderly

Clinical and economic outcomes associated with the use of specific potentially inappropriate medications in the elderly were evaluated.



Raleigh Jones, MD

Latest:

Wait Times, Patient Satisfaction Scores, and the Perception of Care

Clinic wait times do not just affect overall patient satisfaction, but also specifically affect the perception of providers and the quality of care.


Jason C. Simeone, PhD

Latest:

The Incidence and Costs of Hypoglycemia in Type 2 Diabetes

The overall incidence of hypoglycemia was considerable in this large working-age population and was associated with $52 million (2008 dollars) in direct medical costs.




Adam B. Wilcox, PhD

Latest:

Community-Based Health Information Technology Alliances: Potential Predictors of Early Sustainability

Communities led by health information organizations were more likely than those led by healthcare organizations to receive ongoing funding for implementing health information technology.


John W. Peabody, MD, PhD, DTM&H, FACP

Latest:

New Thinking on Clinical Utility: Hard Lessons for Molecular Diagnostics

The authors describe 5 basic requirements for planning, implementing, and proving clinical utility for diagnostic tests, drawing on recent reimbursement decisions.


Navendu Samant, MS

Latest:

Resource Utilization With Insulin Pump Therapy for Type 2 Diabetes Mellitus

A retrospective claims analysis of managed care enrollees with type 2 diabetes mellitus showed that insulin pump therapy reduced antidiabetic drug and healthcare resource use.






Eric A. Finkelstein, PhD

Latest:

The Personal Financial Burden of Cancer for the Working-Aged Population

Being actively treated for cancer increases the mean annual out-of-pocket medical expenditures by $1170 compared with not having cancer.


Jeffrey M. Beaubien, PhD

Latest:

Using Simulation to Identify and Resolve Threats to Patient Safety

The same simulation methodology used in the aviation industry was able to uncover latent environmental threats to patient safety.


Jung Hyun Kim, PhD, MPH

Latest:

Does Care Consultation Affect Use of VHA Versus Non-VHA Care?

Uncoordinated multisystem use is problematic for Veterans Health Administration (VHA) patients with dementia. The Partners in Dementia Care intervention is successful in changing the pattern of VHA versus non-VHA use.


Dan Sherman, MA

Latest:

Impact of Trained Oncology Financial Navigators on Patient Out-of-Pocket Spending

Hospitals that used trained financial navigators were able to provide financial assistance for their patients with cancer, providing access to care that would otherwise be unaffordable.


Bruce G. Vanderver, MD, MPH

Latest:

Annual Diabetic Eye Examinations in a Managed Care Medicaid Population

We assessed challenges and barriers to annual diabetic eye examinations for a managed care Medicaid population and make recommendations to improve population-level screening.




Hong Lu, PhD

Latest:

Evaluation of Electronic Medical Record Administrative Data Linked Database (EMRALD)

The combination of electronic medical record data and administrative data provides the fullest picture of patient health histories.


Emmy Suhl, MEd, RD, CDE

Latest:

CHAPTER 3. Guideline for Detection and Management of Diabetes in Pregnancy

From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts


Joseph Biskupiak, PhD, MBA

Latest:

Oral Anticoagulant Discontinuation in Patients With Nonvalvular Atrial Fibrillation

The risk of discontinuation of oral anticoagulant therapy (both warfarin and direct oral anticoagulant therapies [DOACs]) among nonvalvular atrial fibrillation patients was high. Although the hazard ratio for discontinuation favors DOACs, it is unlikely that the small difference in discontinuation relative to warfarin is clinically meaningful.


Hubertus J. M. Vrijhoef, PhD

Latest:

Toward Tailored Disease Management for Type 2 Diabetes

The heterogeneous nature of care processes and patients should be taken into account in both the design and evaluation of disease management programs for diabetes.


Arianne M. J. Elissen, MSc

Latest:

Toward Tailored Disease Management for Type 2 Diabetes

The heterogeneous nature of care processes and patients should be taken into account in both the design and evaluation of disease management programs for diabetes.



Landon Z. Marshall, PharmD

Latest:

Direct Oral Anticoagulant Prescription Trends, Switching Patterns, and Adherence in Texas Medicaid

Direct oral anticoagulants (DOACs) are associated with increased prescription costs. Actual practice data show a high switch rate and poor adherence among DOAC initiators that need to be addressed.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo